Income Statement (ASTRIA/THERAPEUTICS)

Technical Analysis Historical Data Financials News & Analysis

ASTRIA/THERAPEUTICS NEWS

Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives Consensus Rating of “Buy” from Analysts By MarketBeat - 2 days ago

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has earned a consensus rating of “Buy” from the seven ratings firms that are covering the firm, MarketBeat.com reports. Five equities researc… [+3728 chars]...

Read more
4,600 Shares in Astria Therapeutics, Inc. (NASDAQ:ATXS) Purchased by KLP Kapitalforvaltning AS By MarketBeat - 2 weeks ago

KLP Kapitalforvaltning AS purchased a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 4,600 shares of th… [+3947 chars]...

Read more
Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Target Price at $26.60 By MarketBeat - 4 weeks ago

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. … [+4007 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		181.6 -0.4
-0.22%
CVX 		134.78 -4.52
-3.24%
CAT 		303.93 -3.48
-1.13%
INTC 		19.76 -0.58
-2.85%
MSFT 		389.44 -4.6
-1.17%
DIS 		89.78 -1.39
-1.52%
DOW 		29.89 -0.76
-2.49%
CSCO 		57.18 -0.17
-0.29%
GS 		541.78 -7.14
-1.3%